Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Live Better, Heal Better: Employee Wellness in Workers’ Comp

Strategies for addressing comorbidities, fatigue, and mental health to positively impact claims
Spring/Summer 2020

A New Routine: The Growth of Complex Claims and How to Manage Them

Potential causes and solutions for increasing claims complexity
Spring/Summer 2020

State of the States

A roundup of regulatory activity around the country
Spring/Summer 2020

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

As the market grows, it becomes necessary to understand efficacy, costs, and alternatives.
Mar 2024

CWCI Reports on Cumulative Trauma in Litigated Claims

Tenure more than age and other factors had a higher association with cumulative trauma claims.
Mar 2024

AI Utilization Review Bills Appear Across the Country

California, Georgia, New York, Oklahoma, and Pennsylvania could start a national trend.
Mar 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.
Nov 2018

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.
Sep 2018

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.
Aug 2018
1 21 22 23 24 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle